Junichiro Watanabe
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
-
- MRI in cancer diagnosis
- Radiomics and Machine Learning in Medical Imaging
- Medical Imaging Techniques and Applications
Papers in
- Oncology 68
- HER2/EGFR in Cancer Research 34
- Cancer Treatment and Pharmacology 31
-
- Advanced Breast Cancer Therapies 15
- Lung Cancer Treatments and Mutations 12
- Co-authors
- Takayoshi Uematsu (15 shared papers)Masako Kasami (8 shared papers)Kaoru Takahashi (11 shared papers)Yukiko Tadokoro (10 shared papers)Hiroji Iwata (9 shared papers)Haruki Kondo (6 shared papers)Toshiaki Saeki (5 shared papers)Takeshi Aramaki (3 shared papers)
- Journals
- Annals of Oncology (13 papers)Breast Cancer (9 papers)Breast Cancer Research and Treatment (9 papers)Cancer Research (4 papers)Cancer Chemotherapy and Pharmacology (4 papers)
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Junichiro Watanabe
115 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 100
- Oncology 654
- Radiology, Nuclear Medicine and Imaging 471
- Cancer Research 279
- Pathology and Forensic Medicine 220
- Pulmonary and Respiratory Medicine 382
Countries citing papers authored by Junichiro Watanabe
This map shows the geographic impact of Junichiro Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichiro Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichiro Watanabe more than expected).
Fields of papers citing papers by Junichiro Watanabe
This network shows the impact of papers produced by Junichiro Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichiro Watanabe. The network helps show where Junichiro Watanabe may publish in the future.
Co-authors
The 25 scholars most cited alongside Junichiro Watanabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 97 | |
| 2 | 2019 | 96 | |
| 3 | 2011 | 83 | |
| 4 | 2009 | 68 | |
| 5 | 2012 | 55 | |
| 6 | 2013 | 54 | |
| 7 | 2020 | 45 | |
| 8 | 2021 | 37 | |
| 9 | 2010 | 35 | |
| 10 | 2021 | 32 | |
| 11 | 2017 | 28 | |
| 12 | 2020 | 27 | |
| 13 | 2015 | 25 | |
| 14 | 2014 | 25 | |
| 15 | 2015 | 25 | |
| 16 | 1992 | 24 | |
| 17 | 2011 | 24 | |
| 18 | 2022 | 24 | |
| 19 | 2020 | 23 | |
| 20 | 2012 | 23 |
About Junichiro Watanabe
Junichiro Watanabe is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Cancer Research, having authored 126 papers that have together received 1.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (34 papers), Cancer Treatment and Pharmacology (31 papers), Advanced Breast Cancer Therapies (15 papers), Breast Cancer Treatment Studies (13 papers), Lung Cancer Treatments and Mutations (12 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), MRI in cancer diagnosis (9 papers) and Breast Lesions and Carcinomas (9 papers). The work is most often cited by research in Oncology (654 citations), Radiology, Nuclear Medicine and Imaging (471 citations), Cancer Research (279 citations), Pathology and Forensic Medicine (220 citations) and Pulmonary and Respiratory Medicine (382 citations). Junichiro Watanabe has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Takayoshi Uematsu, Masako Kasami, Kaoru Takahashi, Yukiko Tadokoro, Hiroji Iwata, Haruki Kondo, Toshiaki Saeki, Takeshi Aramaki, Takashi Sugino and Masahiro Endo. Their work appears in journals such as Annals of Oncology, Breast Cancer, Breast Cancer Research and Treatment, Cancer Research and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.